Department of Development Technology of Marine Resources, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, China.
Mar Drugs. 2021 Nov 10;19(11):629. doi: 10.3390/md19110629.
The actinomycetes have proven to be a rich source of bioactive secondary metabolites and play a critical role in the development of pharmaceutical researches. With interactions of host organisms and having special ecological status, the actinomycetes associated with marine animals, marine plants, macroalgae, cyanobacteria, and lichens have more potential to produce active metabolites acting as chemical defenses to protect the host from predators as well as microbial infection. This review focuses on 536 secondary metabolites (SMs) from actinomycetes associated with these marine organisms covering the literature to mid-2021, which will highlight the taxonomic diversity of actinomycetes and the structural classes, biological activities of SMs. Among all the actinomycetes listed, members of (68%), (6%), and (3%) are dominant producers of secondary metabolites. Additionally, alkaloids (37%), polyketides (33%), and peptides (15%) comprise the largest proportion of natural products with mostly antimicrobial activity and cytotoxicity. Furthermore, the data analysis and clinical information of SMs have been summarized in this article, suggesting that some of these actinomycetes with multiple host organisms deserve more attention to their special ecological status and genetic factors.
放线菌已被证明是生物活性次生代谢物的丰富来源,在药物研究的发展中起着至关重要的作用。与宿主生物相互作用并具有特殊生态地位的与海洋动物、海洋植物、大型藻类、蓝细菌和地衣相关的放线菌具有更大的潜力产生具有化学防御作用的活性代谢物,以保护宿主免受捕食者和微生物感染。本文重点介绍了截至 2021 年年中,从与这些海洋生物相关的放线菌中分离得到的 536 种次生代谢产物(SMs),重点介绍了放线菌的分类多样性和 SMs 的结构类别、生物活性。在所列出的所有放线菌中,(68%)、(6%)和(3%)的成员是次生代谢产物的主要生产者。此外,生物碱(37%)、聚酮(33%)和肽(15%)构成了具有大多数抗菌和细胞毒性的天然产物的最大比例。此外,本文还对 SMs 的数据分析和临床信息进行了总结,表明其中一些具有多种宿主生物的放线菌因其特殊的生态地位和遗传因素值得更多关注。